Company profile
About :: MicroPharm
MicroPharm is a fully integrated developer and manufacturer of ovine polyclonal therapeutics, primarily targeting infectious disease and acute toxic events.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
SH01 | Transaction MzUxMjk3MjcxOGFkaXF6a2N4
Published 27 Mar 2026 12:32
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQzMzc4MTY3MGFkaXF6a2N4
Published 29 Aug 2024 08:32
Company registered at Companies House
1 Feb 2017 to 31 Jul 2018
Clostridium difficile infections are the commonest cause of healthcare associated infection in the developed world and mainly involve the elderly. Such infections far outnumber MRSA, have a significant mortality and cost the NHS some £400 million annually. The clinical manifestations are due to the release of two powerful toxins into the lower bowel and t...
1 Nov 2013 to 31 Oct 2016
One of the commonest causes of hospital acquired infection is the bacterium Clostridium difficile which causes diarrhoea and other effects by releasing two powerful toxins. Such infections far outnumber those due to MRSA and the Centre for Disease Control and Prevention in the USA has noted “...the incidence of deaths from C.difficile is greater than the ...
